Sunny Pharmtech Inc.
6676.TWO
Price:
$14.1
Market Cap:
$2.10B
Sunny Pharmtech Inc. engages in the research, development, production, and sale of drug substances and products, and active pharmaceutical ingredients in Taiwan and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; aminocaproic acid tablets for blood diseases, as well as for hyper-proteolytic enzymes; and carboprost tromethamine injection for therapeutic abo...[Read more]
Industry
Biotechnology
IPO Date
2022-01-19
Stock Exchange
TWO
Ticker
6676.TWO
PE Ratio
[-7.75]
ROE
[-27.76%]
Current Ratio
[1.30]
Dividend Yield
[0%]
Enterprise Value
[2.46B]
Dividend History
The ROE as of December 2025 (TTM) for Sunny Pharmtech Inc. (6676.TWO) is -27.76%
According to Sunny Pharmtech Inc.’s latest financial reports and current stock price. The company's current ROE is -27.76%. This represents a change of 241.29% compared to the average of -8.13% of the last 4 quarters.
Sunny Pharmtech Inc. (6676.TWO) Historical ROE (quarterly & annually)
How has 6676.TWO ROE performed in the past?
The mean historical ROE of Sunny Pharmtech Inc. over the last ten years is -13.79%. The current -27.76% ROE has changed 101.30% with respect to the historical average. Over the past ten years (40 quarters), 6676.TWO's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the June 2025 quarter at -17.08%.
Average
-13.79%
Median
-15.21%
Minimum
-19.74%
Maximum
-5.28%
Sunny Pharmtech Inc. (6676.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Sunny Pharmtech Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 182.44%
Maximum Annual ROE = -5.28%
Minimum Annual Increase = -69.95%
Minimum Annual ROE = -19.74%
| Year | ROE | Change |
|---|---|---|
| 2024 | -14.90% | 182.44% |
| 2023 | -5.28% | -69.95% |
| 2022 | -17.56% | 13.19% |
| 2021 | -15.52% | 59.25% |
| 2020 | -9.74% | -50.65% |
Sunny Pharmtech Inc. (6676.TWO) Average ROE
How has 6676.TWO ROE performed in the past?
The current ROE of Sunny Pharmtech Inc. (6676.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.58%
5-year avg
-12.60%
10-year avg
-13.79%
Sunny Pharmtech Inc. (6676.TWO) ROE vs. Peers
How is 6676.TWO’s ROE compared to its peers?
Sunny Pharmtech Inc.’s ROE is greater than Genomics BioSci & Tech. Co.,Ltd. (-31.04%), greater than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (-2.06%), greater than Advagene Biopharma Co., Ltd. (-34.85%), less than Greenyn Biotechnology Co., Ltd (16.75%), greater than Hcmed (-68.42%), greater than GlycoNex Incorporation (-19.51%), greater than MegaPro Biomedical Co., Ltd (-91.17%), greater than Enimmune corporation (-70.32%), greater than Intech Biopharm Corporation (-35.97%), greater than Meribank Biotech Co., Ltd (-5.56%),
| Company | ROE | Market cap |
|---|---|---|
| -31.04% | $1.74B | |
| -2.06% | $1.92B | |
| -34.85% | $1.74B | |
| 16.75% | $2.07B | |
| -68.42% | $2.29B | |
| -19.51% | $2.33B | |
| -91.17% | $994.05M | |
| -70.32% | $1.44B | |
| -35.97% | $2.46B | |
| -5.56% | $1.67B |
Build a custom stock screener for Sunny Pharmtech Inc. (6676.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sunny Pharmtech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Sunny Pharmtech Inc. (6676.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Sunny Pharmtech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Sunny Pharmtech Inc.'s ROE?
How is the ROE calculated for Sunny Pharmtech Inc. (6676.TWO)?
What is the highest ROE for Sunny Pharmtech Inc. (6676.TWO)?
What is the 3-year average ROE for Sunny Pharmtech Inc. (6676.TWO)?
What is the 5-year average ROE for Sunny Pharmtech Inc. (6676.TWO)?
How does the current ROE for Sunny Pharmtech Inc. (6676.TWO) compare to its historical average?